MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.7130
-0.0260
-3.52%
Opening 11:19 12/05 EST
OPEN
0.7400
PREV CLOSE
0.7390
HIGH
0.7400
LOW
0.7062
VOLUME
22.52K
TURNOVER
--
52 WEEK HIGH
1.610
52 WEEK LOW
0.6000
MARKET CAP
44.78M
P/E (TTM)
-3.7546
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTSO last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at CTSO last week (1117-1121)?
Weekly Report · 11/24 10:21
CytoSorbents CEO Phillip P. Chan Reports Acquisition of Common Shares
Reuters · 11/21 02:10
CytoSorbents Corporation to Present at Jefferies Global Healthcare Conference
Reuters · 11/17 22:43
Weekly Report: what happened at CTSO last week (1110-1114)?
Weekly Report · 11/17 10:21
CytoSorbents Corporation reports Q3 2025 revenue of $9.5 million
Reuters · 11/15 05:25
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
TipRanks · 11/15 00:19
Cytosorbents Price Target Maintained With a $10.00/Share by D. Boral Capital
Dow Jones · 11/14 20:55
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.